共 50 条
- [2] Alzheimer?s disease: FDA approves lecanemab amid cost and safety concerns BMJ-BRITISH MEDICAL JOURNAL, 2023, 380 : p73
- [3] Lecanemab: European drug agency rejects Alzheimer's ' s drug amid debate over efficacy and safety BMJ-BRITISH MEDICAL JOURNAL, 2024, 386
- [4] Alzheimer Drug Lecanemab Gains Traditional FDA Approval JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, : 495
- [6] First causally acting Drug against Alzheimer's? The FDA approves Aducanumab NERVENARZT, 2022, 93 (04): : 410 - 412
- [7] FDA approves controversial Alzheimer's drug despite uncertainty over effectiveness BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
- [10] Alzheimer's disease: Lecanemab gets full FDA approval and black box safety warning BMJ-BRITISH MEDICAL JOURNAL, 2023, 382 : p1580